{"ticker": {"uuid": "df780ffa-a51e-4bdc-8361-02c96893e1e5", "symbol": "OABI", "name": "OmniAb Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "OmniAb Names Amechi Nwachuku Chief Operating Officer", "summary": "OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective immediately. Nwachuku brings over 25 years of experience in leading global life sciences tools businesses and will primarily manage the strategy and", "url": "https://www.nasdaq.com/press-release/omniab-names-amechi-nwachuku-chief-operating-officer-2026-07-13", "source_name": "Nasdaq", "published_at": "2026-07-14T08:42:19", "published_display": "14 Jul 2026 08:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb appoints Amechi Nwachuku as chief operating officer", "summary": "OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer, a new role focused on strategy, operations, and commercial aspects of its xPloration platform. Nwachuku brings over 25 years of experience in life sciences and has he", "url": "https://www.investing.com/news/company-news/omniab-appoints-amechi-nwachuku-as-chief-operating-officer-93CH-4788394", "source_name": "Investing.com", "published_at": "2026-07-13T20:44:03", "published_display": "13 Jul 2026 20:44", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Appoints Amechi Nwachuku as Chief Operating Officer \u2013 Leadership Update July 2026", "summary": "OmniAb, Inc. has filed a routine Form 8-K with the SEC on July 13, 2026, which does not contain any price-sensitive or material news. The filing updates standard company and security information but discloses no new operational, financial, strategic developments, or changes in di", "url": "https://www.minichart.com.sg/2026/07/13/omniab-inc-appoints-amechi-nwachuku-as-chief-operating-officer-leadership-update-july-2026/", "source_name": "Minichart", "published_at": "2026-07-13T16:12:08", "published_display": "13 Jul 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Omniab, Inc. Announces Appointment of Amechi Nwachuku to Executive Vice President and Chief Operating Officer, Effective July 13, 2026", "summary": "OmniAb, Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective July 13, 2026. Nwachuku brings over two decades of global life sciences leadership experience from companies including Thermo Fisher Scientific, Danaher's SCIEX a", "url": "https://www.marketscreener.com/news/omniab-inc-announces-appointment-of-amechi-nwachuku-to-executive-vice-president-and-chief-operatin-ce7f5edcd88ef225", "source_name": "www.marketscreener.com", "published_at": "2026-07-13T15:12:08", "published_display": "13 Jul 2026 15:12", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Taps Amechi Nwachuku as Executive Vice President & Chief Operating Officer", "summary": "OmniAb Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer (COO). In this role, Nwachuku will be responsible for overseeing the strategy, operations, and commercial maximization of OmniAb\u2019s xPloration platform. He brings over 25 year", "url": "https://www.contractpharma.com/breaking-news/omniab-taps-amechi-nwachuku-as-executive-vice-president-chief-operating-officer/", "source_name": "Contract Pharma", "published_at": "2026-07-13T15:12:08", "published_display": "13 Jul 2026 15:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb stock rises after naming new chief operating officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPZTBaU1A0WlBQaXRvZzFybC02dFZuTndOZTFWVERPSzRibmRrbGtKWGh3NnZxRlQ1T0tqYlBkajJ1Ni1sMGtnNVV5UjliM3EwLV9TeFdQQ2stdGc5M2drTVE1M3pHRFZFM2RmY3VrVFI0eUk5V0E2RXpFRzdfS3NYNkNlVW5oQVRETXFadS1CbThKaUJoVkVmOG5WUXRGSTJrOGpGalFFYVpHSE1kUXVJaHUzSEtoVmxSZGg3aDNn?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T13:22:13+00:00", "published_display": "13 Jul 2026 13:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb appoints Amechi Nwachuku as chief operating officer By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMFE0eEJLVnc1MjVMcU1oMU94cTgtZkVocW9XUV9qcVBQOUd4RmV1TksxYWR6Nk5CUl81TzJNdVhpaUQyZ3kwSXV4U1lkREd5WW02REdIbTR0X0pEX0VkNndobW15eWtnSFRjV2c4cDd2c29ZTkpyOEVUZ1NTd0hyWk9Sd2N4T0FCMFhKRjV1b3BLQjdwQ1daUkMxeG0wdGt1U0NONTZpeG5qcEZib1dGSk9oT2tSalZVXzV3?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-13T12:57:54+00:00", "published_display": "13 Jul 2026 12:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "OmniAb Appoints Amechi Nwachuku COO to Expand xPloration Platform Commercialization", "summary": "OmniAb Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer to lead the strategy, operations, and commercial expansion of its xPloration\u00ae antibody discovery platform. Nwachuku brings over 25 years of experience in life sciences", "url": "https://www.citybiz.co/article/873099/omniab-appoints-amechi-nwachuku-coo-to-expand-xploration-platform-commercialization/", "source_name": "citybiz", "published_at": "2026-07-13T13:12:08", "published_display": "13 Jul 2026 13:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thermo Fisher veteran Amechi Nwachuku takes OmniAb COO role", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOcHBPa2V0bmt2Nk13dlVxWVFGU1FUTUJKYjZyc0hGYXUzaldCN25pazZmY1AyOG1qOUNlaFVGZjR5UE9QSXlzRjdZR2FqSmxlNmhQc09yZWYzbTRla0VQUnRicVM1RUFieVhhbkoyclp0Y0cxSTNJQVhUTlFPUGRPQ3FQWVJIbDhLdHVDNmJ5OEZYY3F5QV9HajExdC11YUdtU2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T12:02:50+00:00", "published_display": "13 Jul 2026 12:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amechi Nwachuku named COO at OmniAb with stock options and severance", "summary": "OmniAb has appointed Amechi Nwachuku as Chief Operating Officer, effective July 13, 2026. His compensation package includes an initial annual base salary of $445,000, a target bonus of 45% of base salary, and a grant of options to purchase 800,000 shares. Nwachuku is also eligibl", "url": "https://www.tradingview.com/news/tradingview:5cafc959f40ec:0-amechi-nwachuku-named-coo-at-omniab-with-stock-options-and-severance/", "source_name": "TradingView", "published_at": "2026-07-13T12:12:08", "published_display": "13 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Inc. (OABI) Climbs 2.23% as Shares Approach Key Resistance at $2.40 - Strangle Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQSHRnbmR4cEhScFF2ZTNrWU5VNm1lZ2d6RDJGcUpiU3RYQUc0UGt2M29wR08talFPWkRwRjBFVDN4V0NMU2luZDgtR19NYzFJMEVmRmdFZTJFZGY5QUJXNEhrNGhLclRJR1FyZWEzVnlWOW9nWFgyOXdqREhiS1FlV09RZGFiSDVrd2N2TW90TXhkcFNTc0JINUZIbVY3QVJXTjFsd0QtTEVBLXNpaTB3NEp3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-12T17:38:26+00:00", "published_display": "12 Jul 2026 17:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OABI,VKTX Revenue Breakdown", "summary": "This article provides a financial overview and key performance indicators for two biotechnology companies: OmniAb Inc. (OABI) and Viking Therapeutics Inc. (VKTX). It details their market capitalization, income, sales, various financial ratios, stock performance, and analyst recom", "url": "https://finviz.com/stock?t=OABI%2CVKTX&p=m&ty=rv&r=y5", "source_name": "Finviz", "published_at": "2026-07-07T06:41:05", "published_display": "07 Jul 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Price Target Decreased by 13.73% to 7.48", "summary": "The article reports that the price target for OmniAb (OABI) has been decreased by 13.73%, bringing the new target to $7.48. This information solely focuses on the updated financial outlook for the company's stock.", "url": "http://www.msn.com/en-us/money/topstocks/omniab-oabi-price-target-decreased-by-1373-to-748/ar-AA1QA2Xf?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-05T07:09:24", "published_display": "05 Jul 2026 07:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OABI - OmniAb Inc Volatility & Greeks", "summary": "This article provides a detailed financial overview of OmniAb Inc (OABI), including its stock performance metrics, volatility, and various financial ratios. It lists key data such as market capitalization, income, sales, and per-share values, alongside insider ownership, institut", "url": "https://finviz.com/stock?t=OABI&ty=ocv&e=2026-07-17", "source_name": "Finviz", "published_at": "2026-07-04T17:40:53", "published_display": "04 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher?", "summary": "OmniAb, Inc. (NASDAQ: OABI) has seen significant gains, rising over 38% in the past six months and 74% since its Q1 2026 earnings release. The company's revenue surged from $4.2 million to $14.4 million in Q1 2026, driven by milestone payments, while R&D and G&A costs decreased, ", "url": "https://www.insidermonkey.com/blog/omniab-oabi-gains-more-than-38-over-6-months-can-it-go-higher-1794177/", "source_name": "Insider Monkey", "published_at": "2026-07-03T09:13:00", "published_display": "03 Jul 2026 09:13", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive listing of OmniAb, Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports, 8-Ks, 10-Qs, and 10-Ks. It details corporate events, investor updates, and press releases, offering insights into the company's ", "url": "https://www.tradingview.com/symbols/NASDAQ-OABIW/documents/", "source_name": "TradingView", "published_at": "2026-07-02T09:39:24", "published_display": "02 Jul 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive list of OmniAb, Inc.'s financial disclosures and SEC filings, including earnings reports (Forms 10-K, 10-Q, 8-K), corporate presentations, and investor updates stretching from Q1 2026 back to Q4 2021. It details key highlights for each filing", "url": "https://www.tradingview.com/symbols/BOATS-OABI/documents/", "source_name": "TradingView", "published_at": "2026-07-01T22:10:32", "published_display": "01 Jul 2026 22:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About OmniAb's (NASDAQ:OABI) Cash Burn Rate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-30T11:51:38+00:00", "published_display": "30 Jun 2026 11:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2500 Growth Benchmark", "summary": "OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 2500 Growth Benchmark, a decision officially published on June 29, 2026. This exclusion is part of a broader removal from several Russell benchmarks, including the Russell Microcap Growth, Russell 2000 Growth, Russel", "url": "https://www.marketscreener.com/news/omniab-inc-nasdaqgm-oabi-dropped-from-russell-2500-growth-benchmark-ce7f5fdfdd88f126", "source_name": "marketscreener.com", "published_at": "2026-06-29T19:58:00", "published_display": "29 Jun 2026 19:58", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Preview: OmniAb to Report Financial Results Post-market on May 07", "summary": "OmniAb is scheduled to report its financial results after market close on May 07. This earnings preview indicates that investors and analysts will be closely watching the company's performance. The results will provide insight into the company's financial health and future outloo", "url": "https://www.moomoo.com/news/post/69310814/earnings-preview-omniab-to-report-financial-results-post-market-on", "source_name": "Moomoo", "published_at": "2026-06-29T12:39:30", "published_display": "29 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark", "summary": "OmniAb, Inc. (NasdaqGM: OABI) has been removed from the Russell 2000 Growth Benchmark. This news follows earlier reports of its removal from the Russell Microcap Growth Benchmark Index and the Russell 3000E Growth Benchmark. OmniAb specializes in licensing discovery research tech", "url": "https://www.marketscreener.com/news/omniab-inc-nasdaqgm-oabi-dropped-from-russell-2000-growth-benchmark-ce7f5fded18af321", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T07:27:00", "published_display": "29 Jun 2026 07:27", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000 Growth Benchmark", "summary": "OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 3000 Growth Benchmark. This move follows a series of similar announcements where the company was removed from other Russell indices, including the Russell 2500, Microcap, 2000, 3000E Growth, and Small Cap Comp Growth", "url": "https://www.marketscreener.com/news/omniab-inc-nasdaqgm-oabi-dropped-from-russell-3000-growth-benchmark-ce7f5fdcd18af227", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T18:11:36", "published_display": "28 Jun 2026 18:11", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of OmniAb, Inc. \u2013 BOATS:OABIW", "summary": "This article provides financial information for OmniAb, Inc. under the ticker OABIW, focusing on its enterprise value to revenue forward. It appears to be a financial data page from TradingView, offering an overview of the company's financials without detailed analysis. The conte", "url": "https://www.tradingview.com/symbols/BOATS-OABIW/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T19:39:48", "published_display": "27 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OABI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for OmniAb, Inc. (OABI) stock, including analyst opinions, historical price performance, and financial metrics. It highlights key data such as the current stock price, market capitalization, earnings reports, and volatility, while", "url": "https://www.tradingview.com/symbols/NASDAQ-OABI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T01:41:08", "published_display": "26 Jun 2026 01:41", "sentiment": "positive", "sentiment_pct": 62, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OmniAb, Inc. \u2013 BOATS:OABIW", "summary": "This page provides financial information for OmniAb, Inc. (OABIW), specifically focusing on its price to book forward ratio. The data is presented through TradingView, noting that the market is currently closed with no trades.", "url": "https://www.tradingview.com/symbols/BOATS-OABIW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T01:41:08", "published_display": "26 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Actuals & Estimates (NASDAQ:OABI)", "summary": "This article provides an overview of OmniAb, Inc. (NASDAQ: OABI) stock performance, financial actuals, and analyst estimates. It covers various metrics including current stock price, market capitalization, earnings, revenue, and future forecasts, offering insights into the compan", "url": "https://www.tradingview.com/symbols/NASDAQ-OABI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T00:40:25", "published_display": "26 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OmniAb, Inc. \u2013 BOATS:OABIW", "summary": "This article provides financial information for OmniAb, Inc. under the ticker symbol OABIW on the Blue Ocean Alternative Trade System (BOATS). It specifically highlights the \"Price to earnings forward\" metric. The content appears to be a financial data page from TradingView, show", "url": "https://www.tradingview.com/symbols/BOATS-OABIW/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T17:39:35", "published_display": "25 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of OmniAb Inc (OABI), detailing its price momentum score of 8.80 in the Biotechnology & Medical Research industry, trading between resistance at $2.87 and support at $2.08. It evaluates various technical indicators like MACD, RSI, and mo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oabi/technical", "source_name": "TradingKey", "published_at": "2026-06-24T13:40:25", "published_display": "24 Jun 2026 13:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com", "summary": "OmniAb, Inc. (NASDAQ:OABI) held its 2026 Annual Meeting where shareholders elected Jennifer Cochran, Ph.D., and Matthew W. Foehr as Class I directors for three-year terms. Additionally, Ernst & Young LLP was ratified as the independent registered public accounting firm for the fi", "url": "https://ng.investing.com/news/sec-filings/omniab-shareholders-elect-directors-and-ratify-auditor-at-annual-meeting-93CH-2566468", "source_name": "Investing.com Nigeria", "published_at": "2026-06-19T02:40:23", "published_display": "19 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) director Bertozzi exercises RSUs and receives new option, RSU grants", "summary": "OmniAb director Carolyn R. Bertozzi exercised 20,000 Restricted Stock Units (RSUs) into common stock, increasing her direct holdings to 113,308 shares. She also received grants of 40,000 stock options at an exercise price of $2.03 and 20,000 new RSUs. Both the new RSUs and stock ", "url": "https://www.stocktitan.net/sec-filings/OABI/form-4-omni-ab-inc-insider-trading-activity-00e71f789726.html", "source_name": "Stock Titan", "published_at": "2026-06-18T23:40:35", "published_display": "18 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) 2026 annual meeting elects directors and ratifies auditor", "summary": "OmniAb, Inc. (OABI) held its 2026 Annual Meeting of Shareholders on June 17, 2026. During the meeting, shareholders elected Jennifer Cochran, Ph.D. and Matthew W. Foehr as Class I directors for three-year terms. Additionally, Ernst & Young LLP was ratified as the independent regi", "url": "https://www.stocktitan.net/sec-filings/OABI/8-k-omni-ab-inc-reports-material-event-8056535c331d.html", "source_name": "Stock Titan", "published_at": "2026-06-18T23:10:46", "published_display": "18 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOQjJqT3prb3lTeFFMNExobkJtbm53cE1HcFJmaUdvTU8wbktwTUF3RGx1TllzVjRMZHZMZ2lJM2tRSTFPdHdQd3BEQ04zRmZHNnUyTG1ERlVGTDlXaFlEZUMxYWJoR3k1dEJsbDV3U29tclJ1V095RTFKOW5PSW8ydEw1UXRPa2Y0Tk9IX3FzY2Zvc05ReEhwb0V0QTBEM0tvZDBTbg?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "We're Hopeful That OmniAb (NASDAQ:OABI) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbXBENWVNdVpZcW1wTzkzVmVWTWxyQ19Cd2tBYm1IRFhnUVZMVkZkRk85cjJPalljRmM2WkFfOU5zUEJEbFNfbE5ObU9lUWhQSk9IYmlTd1hWYTlpVzRvTG5KOFlDMlNfLVdsWnA4V1FRbl9GaG1tWkotVkU0NmNZN1RyeXUyUmRfNUNRVVN2VWtBYWhkSWM4?oc=5", "source_name": "Moomoo", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:OABI) 2026-05-11", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNSUVDX3lZaDduOEkwN29KQ3F0SzJQcV93WWlNQ1VtZUhyYm0zTnJrc0M2NDk1Z29OZ2V3bUNTd181Rk44LV9XdVI5YW1GbURrZXVZekZLaFo5UmdGRzg3NENtbjF1ejZmRXpNdkdGbm9od1E2am0wcWFSeXJyNEs3WnBLd0xBUWxURVQySFNqVUpBbTExQmc5UFdR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "OmniAb, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/cf75066e-b98b-3804-ae2c-d119f4123c4f/omniab%2C-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-08T12:30:00+00:00", "published_display": "08 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/b8400842-067c-3d42-b150-2fa6cf40dc36/omniab-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-08T11:07:39+00:00", "published_display": "08 May 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPbFhETmlwRzdDVDJMb29XaW5CcEJnQ2hJaHJiM1JJM0lESEtDOUhiY1hzTTJhQklFb1k0cHJIdl93X1lGSWJTQTNXbk1BM0piX2FQLUdzbFZkaC1WZDlsa1JDRXlRUmVCRzJOSlNobjZJTGNSMXVVaktoaEd3Q0NiUm14UF9IT2czbmh3QUlvUGhQZ3pBcHZaTUx6Smc2Rmc?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Reports First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNS3NTem5JenBVNEVGQ2xPbmk0U3JJeElQSUYyeFpPLXc0NzlQbUVfSTdheXM1cnN6YXlHREotS2Zkc2gzS0QyV016bnZQQVhWMWdmNzNPZWdjZTJzY295aGs3Wkt4MkV1R2JSUmtBQVdNQjhoNjFZT3ktM0J2M2gxNFFwMmVMUDFqVzNrNERfQ0p0VFJxVTc1MEZ4QmdFSDk5bl9Ebjc2eFYzMnYyMGdtdjJKd0tyQQ?oc=5", "source_name": "BioSpace", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQSjBJOHplZUthVDVqSy1qUmxhdmxrRFZRaDZMRW9YT1NzNVFlcW9sOU1FRkRYVHQyazBPRWlmd1piRkJVZFZnUGJrdzRSeXJzeHdaVnJKRGNtOUk4X0RpQVVBV2dxaEc2eHN5ZEpjSzlOUXJFRFFRM1RTWjdLczhUWEpyRTVwejE2OExZbU1wYXV0OGs5cVE?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Inc (OABI) Q1 2026 Earnings Report Preview: What To Expect", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/omniab-inc-oabi-q1-2026-133357783.html", "source_name": "GuruFocus.com", "published_at": "2026-05-06T13:33:57+00:00", "published_display": "06 May 2026 13:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buyers At OmniAb Likely Disappointed With 13% Slide", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Bullish OmniAb Insiders Loaded Up On US$1.28m Of Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPWW91NXZENlJWNmJobnFiX2FXYlB4UXlsVzc2dGJnc1JCVE92X2lNZEhSRUxHd01Jcm9wbGN5V25YdUlpWmR3MFZqX3c3dXotSGFHMWRFaGx3QlNsdEVKZGV0SzFqN0R3cDc5UUlqNl9qZFJJT0F6TU1qN1Qxc19vWjNCSEsxYldvS2VNclZLcEhnTXdLLXJCUWRBS0ozZk0?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "OmniAb (OABI) Well-Positioned for Momentum Build-Up in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObTJZdy05WU51OW9zX09RTGdDZ2lQOFlBU21ELUU4R2pvMTFXdlktV2p2TWEwLW1ENEJUN2Utd1ZpcHJUM3BKUHFucGc5cUtidUt1U1J4Ti12MFJBOFA2UGtuY3V3b1ZoalVncVNaTGc5VzFiV013OFA2UWlPTlRvOG1qZmdLTUhDeGRjZlpKc3pyWEk5UExHdlhZUi15Q19UM251dzdkUW4?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Is Why You Should Not Ignore OmniAb Inc. (OABI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNMFlYYXdrUy14LTJnN2xjWTlJOWZPSWxFY3hvdkZ2d25WMklQcDVFOUpPMDd5NEhvMVBVLVFvbS10ejY4TUVEMDgzQ2M4b1JpWUlFRHNRbGRYeG54OEJxdHV5a29sUmVuWkRkN2ZqdURQWWIzcDU1OUc5VEV5NmktOHlvdWFLOTFldm83dWZWMmlYdjRV?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "OmniAb (OABI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBReWlfUUNXWkkzUTcxLWZ1cWF5aXUwc1ZHckYzWDBlODh4R2xHRlE3N2tLTV9uRUY5VUNyUERaR282ZHJvUkY0eUtydGlwak9xWTFZ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:41:42+00:00", "published_display": "25 Apr 2025 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRU9nT1I3VkhzbF9peGZ1UklHRU1idVdXSy0tdnRmWS1wb0Izc1ZteW1xRnUyZ0t3RWloQzMxWnB0MkdUYWdMSUhwUl92MG5mVmkzTEtQa3ZReDdhMzNMMFhIeHNNME9yUlg5UkRmUDVGS3hmUEVvc2ZCcWhvUHNLSmdQTlBpaU9PR2MxbTVGVGtkUGxabDJSWUZtVHBYZThBUmtYclAyZmh3bjd2S2JiT2JEWXF6MUp5U3JxRFk2clRvX0lIcDFVTUZ6cm9HSm1OWGlEMVBONk5JV0NQZnp4OWtPT1E?oc=5", "source_name": "Business Wire", "published_at": "2022-03-23T07:00:00+00:00", "published_display": "23 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "OmniAb Names Amechi Nwachuku Chief Operating Officer", "summary": "OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective immediately. Nwachuku brings over 25 years of experience in leading global life sciences tools businesses and will primarily manage the strategy and", "url": "https://www.nasdaq.com/press-release/omniab-names-amechi-nwachuku-chief-operating-officer-2026-07-13", "source_name": "Nasdaq", "published_at": "2026-07-14T08:42:19", "published_display": "14 Jul 2026 08:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb appoints Amechi Nwachuku as chief operating officer", "summary": "OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer, a new role focused on strategy, operations, and commercial aspects of its xPloration platform. Nwachuku brings over 25 years of experience in life sciences and has he", "url": "https://www.investing.com/news/company-news/omniab-appoints-amechi-nwachuku-as-chief-operating-officer-93CH-4788394", "source_name": "Investing.com", "published_at": "2026-07-13T20:44:03", "published_display": "13 Jul 2026 20:44", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Appoints Amechi Nwachuku as Chief Operating Officer \u2013 Leadership Update July 2026", "summary": "OmniAb, Inc. has filed a routine Form 8-K with the SEC on July 13, 2026, which does not contain any price-sensitive or material news. The filing updates standard company and security information but discloses no new operational, financial, strategic developments, or changes in di", "url": "https://www.minichart.com.sg/2026/07/13/omniab-inc-appoints-amechi-nwachuku-as-chief-operating-officer-leadership-update-july-2026/", "source_name": "Minichart", "published_at": "2026-07-13T16:12:08", "published_display": "13 Jul 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Omniab, Inc. Announces Appointment of Amechi Nwachuku to Executive Vice President and Chief Operating Officer, Effective July 13, 2026", "summary": "OmniAb, Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective July 13, 2026. Nwachuku brings over two decades of global life sciences leadership experience from companies including Thermo Fisher Scientific, Danaher's SCIEX a", "url": "https://www.marketscreener.com/news/omniab-inc-announces-appointment-of-amechi-nwachuku-to-executive-vice-president-and-chief-operatin-ce7f5edcd88ef225", "source_name": "www.marketscreener.com", "published_at": "2026-07-13T15:12:08", "published_display": "13 Jul 2026 15:12", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Taps Amechi Nwachuku as Executive Vice President & Chief Operating Officer", "summary": "OmniAb Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer (COO). In this role, Nwachuku will be responsible for overseeing the strategy, operations, and commercial maximization of OmniAb\u2019s xPloration platform. He brings over 25 year", "url": "https://www.contractpharma.com/breaking-news/omniab-taps-amechi-nwachuku-as-executive-vice-president-chief-operating-officer/", "source_name": "Contract Pharma", "published_at": "2026-07-13T15:12:08", "published_display": "13 Jul 2026 15:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb stock rises after naming new chief operating officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPZTBaU1A0WlBQaXRvZzFybC02dFZuTndOZTFWVERPSzRibmRrbGtKWGh3NnZxRlQ1T0tqYlBkajJ1Ni1sMGtnNVV5UjliM3EwLV9TeFdQQ2stdGc5M2drTVE1M3pHRFZFM2RmY3VrVFI0eUk5V0E2RXpFRzdfS3NYNkNlVW5oQVRETXFadS1CbThKaUJoVkVmOG5WUXRGSTJrOGpGalFFYVpHSE1kUXVJaHUzSEtoVmxSZGg3aDNn?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T13:22:13+00:00", "published_display": "13 Jul 2026 13:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb appoints Amechi Nwachuku as chief operating officer By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMFE0eEJLVnc1MjVMcU1oMU94cTgtZkVocW9XUV9qcVBQOUd4RmV1TksxYWR6Nk5CUl81TzJNdVhpaUQyZ3kwSXV4U1lkREd5WW02REdIbTR0X0pEX0VkNndobW15eWtnSFRjV2c4cDd2c29ZTkpyOEVUZ1NTd0hyWk9Sd2N4T0FCMFhKRjV1b3BLQjdwQ1daUkMxeG0wdGt1U0NONTZpeG5qcEZib1dGSk9oT2tSalZVXzV3?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-13T12:57:54+00:00", "published_display": "13 Jul 2026 12:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Appoints Amechi Nwachuku COO to Expand xPloration Platform Commercialization", "summary": "OmniAb Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer to lead the strategy, operations, and commercial expansion of its xPloration\u00ae antibody discovery platform. Nwachuku brings over 25 years of experience in life sciences", "url": "https://www.citybiz.co/article/873099/omniab-appoints-amechi-nwachuku-coo-to-expand-xploration-platform-commercialization/", "source_name": "citybiz", "published_at": "2026-07-13T13:12:08", "published_display": "13 Jul 2026 13:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thermo Fisher veteran Amechi Nwachuku takes OmniAb COO role", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOcHBPa2V0bmt2Nk13dlVxWVFGU1FUTUJKYjZyc0hGYXUzaldCN25pazZmY1AyOG1qOUNlaFVGZjR5UE9QSXlzRjdZR2FqSmxlNmhQc09yZWYzbTRla0VQUnRicVM1RUFieVhhbkoyclp0Y0cxSTNJQVhUTlFPUGRPQ3FQWVJIbDhLdHVDNmJ5OEZYY3F5QV9HajExdC11YUdtU2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T12:02:50+00:00", "published_display": "13 Jul 2026 12:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amechi Nwachuku named COO at OmniAb with stock options and severance", "summary": "OmniAb has appointed Amechi Nwachuku as Chief Operating Officer, effective July 13, 2026. His compensation package includes an initial annual base salary of $445,000, a target bonus of 45% of base salary, and a grant of options to purchase 800,000 shares. Nwachuku is also eligibl", "url": "https://www.tradingview.com/news/tradingview:5cafc959f40ec:0-amechi-nwachuku-named-coo-at-omniab-with-stock-options-and-severance/", "source_name": "TradingView", "published_at": "2026-07-13T12:12:08", "published_display": "13 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Inc. (OABI) Climbs 2.23% as Shares Approach Key Resistance at $2.40 - Strangle Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQSHRnbmR4cEhScFF2ZTNrWU5VNm1lZ2d6RDJGcUpiU3RYQUc0UGt2M29wR08talFPWkRwRjBFVDN4V0NMU2luZDgtR19NYzFJMEVmRmdFZTJFZGY5QUJXNEhrNGhLclRJR1FyZWEzVnlWOW9nWFgyOXdqREhiS1FlV09RZGFiSDVrd2N2TW90TXhkcFNTc0JINUZIbVY3QVJXTjFsd0QtTEVBLXNpaTB3NEp3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-12T17:38:26+00:00", "published_display": "12 Jul 2026 17:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OABI,VKTX Revenue Breakdown", "summary": "This article provides a financial overview and key performance indicators for two biotechnology companies: OmniAb Inc. (OABI) and Viking Therapeutics Inc. (VKTX). It details their market capitalization, income, sales, various financial ratios, stock performance, and analyst recom", "url": "https://finviz.com/stock?t=OABI%2CVKTX&p=m&ty=rv&r=y5", "source_name": "Finviz", "published_at": "2026-07-07T06:41:05", "published_display": "07 Jul 2026 06:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Price Target Decreased by 13.73% to 7.48", "summary": "The article reports that the price target for OmniAb (OABI) has been decreased by 13.73%, bringing the new target to $7.48. This information solely focuses on the updated financial outlook for the company's stock.", "url": "http://www.msn.com/en-us/money/topstocks/omniab-oabi-price-target-decreased-by-1373-to-748/ar-AA1QA2Xf?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-05T07:09:24", "published_display": "05 Jul 2026 07:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OABI - OmniAb Inc Volatility & Greeks", "summary": "This article provides a detailed financial overview of OmniAb Inc (OABI), including its stock performance metrics, volatility, and various financial ratios. It lists key data such as market capitalization, income, sales, and per-share values, alongside insider ownership, institut", "url": "https://finviz.com/stock?t=OABI&ty=ocv&e=2026-07-17", "source_name": "Finviz", "published_at": "2026-07-04T17:40:53", "published_display": "04 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher?", "summary": "OmniAb, Inc. (NASDAQ: OABI) has seen significant gains, rising over 38% in the past six months and 74% since its Q1 2026 earnings release. The company's revenue surged from $4.2 million to $14.4 million in Q1 2026, driven by milestone payments, while R&D and G&A costs decreased, ", "url": "https://www.insidermonkey.com/blog/omniab-oabi-gains-more-than-38-over-6-months-can-it-go-higher-1794177/", "source_name": "Insider Monkey", "published_at": "2026-07-03T09:13:00", "published_display": "03 Jul 2026 09:13", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive listing of OmniAb, Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports, 8-Ks, 10-Qs, and 10-Ks. It details corporate events, investor updates, and press releases, offering insights into the company's ", "url": "https://www.tradingview.com/symbols/NASDAQ-OABIW/documents/", "source_name": "TradingView", "published_at": "2026-07-02T09:39:24", "published_display": "02 Jul 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Financial Disclosures & SEC Filings", "summary": "This article provides a comprehensive list of OmniAb, Inc.'s financial disclosures and SEC filings, including earnings reports (Forms 10-K, 10-Q, 8-K), corporate presentations, and investor updates stretching from Q1 2026 back to Q4 2021. It details key highlights for each filing", "url": "https://www.tradingview.com/symbols/BOATS-OABI/documents/", "source_name": "TradingView", "published_at": "2026-07-01T22:10:32", "published_display": "01 Jul 2026 22:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About OmniAb's (NASDAQ:OABI) Cash Burn Rate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-30T11:51:38+00:00", "published_display": "30 Jun 2026 11:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2500 Growth Benchmark", "summary": "OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 2500 Growth Benchmark, a decision officially published on June 29, 2026. This exclusion is part of a broader removal from several Russell benchmarks, including the Russell Microcap Growth, Russell 2000 Growth, Russel", "url": "https://www.marketscreener.com/news/omniab-inc-nasdaqgm-oabi-dropped-from-russell-2500-growth-benchmark-ce7f5fdfdd88f126", "source_name": "marketscreener.com", "published_at": "2026-06-29T19:58:00", "published_display": "29 Jun 2026 19:58", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Preview: OmniAb to Report Financial Results Post-market on May 07", "summary": "OmniAb is scheduled to report its financial results after market close on May 07. This earnings preview indicates that investors and analysts will be closely watching the company's performance. The results will provide insight into the company's financial health and future outloo", "url": "https://www.moomoo.com/news/post/69310814/earnings-preview-omniab-to-report-financial-results-post-market-on", "source_name": "Moomoo", "published_at": "2026-06-29T12:39:30", "published_display": "29 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark", "summary": "OmniAb, Inc. (NasdaqGM: OABI) has been removed from the Russell 2000 Growth Benchmark. This news follows earlier reports of its removal from the Russell Microcap Growth Benchmark Index and the Russell 3000E Growth Benchmark. OmniAb specializes in licensing discovery research tech", "url": "https://www.marketscreener.com/news/omniab-inc-nasdaqgm-oabi-dropped-from-russell-2000-growth-benchmark-ce7f5fded18af321", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T07:27:00", "published_display": "29 Jun 2026 07:27", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000 Growth Benchmark", "summary": "OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 3000 Growth Benchmark. This move follows a series of similar announcements where the company was removed from other Russell indices, including the Russell 2500, Microcap, 2000, 3000E Growth, and Small Cap Comp Growth", "url": "https://www.marketscreener.com/news/omniab-inc-nasdaqgm-oabi-dropped-from-russell-3000-growth-benchmark-ce7f5fdcd18af227", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T18:11:36", "published_display": "28 Jun 2026 18:11", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of OmniAb, Inc. \u2013 BOATS:OABIW", "summary": "This article provides financial information for OmniAb, Inc. under the ticker OABIW, focusing on its enterprise value to revenue forward. It appears to be a financial data page from TradingView, offering an overview of the company's financials without detailed analysis. The conte", "url": "https://www.tradingview.com/symbols/BOATS-OABIW/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T19:39:48", "published_display": "27 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OABI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for OmniAb, Inc. (OABI) stock, including analyst opinions, historical price performance, and financial metrics. It highlights key data such as the current stock price, market capitalization, earnings reports, and volatility, while", "url": "https://www.tradingview.com/symbols/NASDAQ-OABI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T01:41:08", "published_display": "26 Jun 2026 01:41", "sentiment": "positive", "sentiment_pct": 62, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OmniAb, Inc. \u2013 BOATS:OABIW", "summary": "This page provides financial information for OmniAb, Inc. (OABIW), specifically focusing on its price to book forward ratio. The data is presented through TradingView, noting that the market is currently closed with no trades.", "url": "https://www.tradingview.com/symbols/BOATS-OABIW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T01:41:08", "published_display": "26 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Actuals & Estimates (NASDAQ:OABI)", "summary": "This article provides an overview of OmniAb, Inc. (NASDAQ: OABI) stock performance, financial actuals, and analyst estimates. It covers various metrics including current stock price, market capitalization, earnings, revenue, and future forecasts, offering insights into the compan", "url": "https://www.tradingview.com/symbols/NASDAQ-OABI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T00:40:25", "published_display": "26 Jun 2026 00:40", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OmniAb, Inc. \u2013 BOATS:OABIW", "summary": "This article provides financial information for OmniAb, Inc. under the ticker symbol OABIW on the Blue Ocean Alternative Trade System (BOATS). It specifically highlights the \"Price to earnings forward\" metric. The content appears to be a financial data page from TradingView, show", "url": "https://www.tradingview.com/symbols/BOATS-OABIW/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T17:39:35", "published_display": "25 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of OmniAb Inc (OABI), detailing its price momentum score of 8.80 in the Biotechnology & Medical Research industry, trading between resistance at $2.87 and support at $2.08. It evaluates various technical indicators like MACD, RSI, and mo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-oabi/technical", "source_name": "TradingKey", "published_at": "2026-06-24T13:40:25", "published_display": "24 Jun 2026 13:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com", "summary": "OmniAb, Inc. (NASDAQ:OABI) held its 2026 Annual Meeting where shareholders elected Jennifer Cochran, Ph.D., and Matthew W. Foehr as Class I directors for three-year terms. Additionally, Ernst & Young LLP was ratified as the independent registered public accounting firm for the fi", "url": "https://ng.investing.com/news/sec-filings/omniab-shareholders-elect-directors-and-ratify-auditor-at-annual-meeting-93CH-2566468", "source_name": "Investing.com Nigeria", "published_at": "2026-06-19T02:40:23", "published_display": "19 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) director Bertozzi exercises RSUs and receives new option, RSU grants", "summary": "OmniAb director Carolyn R. Bertozzi exercised 20,000 Restricted Stock Units (RSUs) into common stock, increasing her direct holdings to 113,308 shares. She also received grants of 40,000 stock options at an exercise price of $2.03 and 20,000 new RSUs. Both the new RSUs and stock ", "url": "https://www.stocktitan.net/sec-filings/OABI/form-4-omni-ab-inc-insider-trading-activity-00e71f789726.html", "source_name": "Stock Titan", "published_at": "2026-06-18T23:40:35", "published_display": "18 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) 2026 annual meeting elects directors and ratifies auditor", "summary": "OmniAb, Inc. (OABI) held its 2026 Annual Meeting of Shareholders on June 17, 2026. During the meeting, shareholders elected Jennifer Cochran, Ph.D. and Matthew W. Foehr as Class I directors for three-year terms. Additionally, Ernst & Young LLP was ratified as the independent regi", "url": "https://www.stocktitan.net/sec-filings/OABI/8-k-omni-ab-inc-reports-material-event-8056535c331d.html", "source_name": "Stock Titan", "published_at": "2026-06-18T23:10:46", "published_display": "18 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOQjJqT3prb3lTeFFMNExobkJtbm53cE1HcFJmaUdvTU8wbktwTUF3RGx1TllzVjRMZHZMZ2lJM2tRSTFPdHdQd3BEQ04zRmZHNnUyTG1ERlVGTDlXaFlEZUMxYWJoR3k1dEJsbDV3U29tclJ1V095RTFKOW5PSW8ydEw1UXRPa2Y0Tk9IX3FzY2Zvc05ReEhwb0V0QTBEM0tvZDBTbg?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That OmniAb (NASDAQ:OABI) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbXBENWVNdVpZcW1wTzkzVmVWTWxyQ19Cd2tBYm1IRFhnUVZMVkZkRk85cjJPalljRmM2WkFfOU5zUEJEbFNfbE5ObU9lUWhQSk9IYmlTd1hWYTlpVzRvTG5KOFlDMlNfLVdsWnA4V1FRbl9GaG1tWkotVkU0NmNZN1RyeXUyUmRfNUNRVVN2VWtBYWhkSWM4?oc=5", "source_name": "Moomoo", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:OABI) 2026-05-11", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNSUVDX3lZaDduOEkwN29KQ3F0SzJQcV93WWlNQ1VtZUhyYm0zTnJrc0M2NDk1Z29OZ2V3bUNTd181Rk44LV9XdVI5YW1GbURrZXVZekZLaFo5UmdGRzg3NENtbjF1ejZmRXpNdkdGbm9od1E2am0wcWFSeXJyNEs3WnBLd0xBUWxURVQySFNqVUpBbTExQmc5UFdR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/cf75066e-b98b-3804-ae2c-d119f4123c4f/omniab%2C-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-08T12:30:00+00:00", "published_display": "08 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/b8400842-067c-3d42-b150-2fa6cf40dc36/omniab-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-08T11:07:39+00:00", "published_display": "08 May 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPbFhETmlwRzdDVDJMb29XaW5CcEJnQ2hJaHJiM1JJM0lESEtDOUhiY1hzTTJhQklFb1k0cHJIdl93X1lGSWJTQTNXbk1BM0piX2FQLUdzbFZkaC1WZDlsa1JDRXlRUmVCRzJOSlNobjZJTGNSMXVVaktoaEd3Q0NiUm14UF9IT2czbmh3QUlvUGhQZ3pBcHZaTUx6Smc2Rmc?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Reports First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNS3NTem5JenBVNEVGQ2xPbmk0U3JJeElQSUYyeFpPLXc0NzlQbUVfSTdheXM1cnN6YXlHREotS2Zkc2gzS0QyV016bnZQQVhWMWdmNzNPZWdjZTJzY295aGs3Wkt4MkV1R2JSUmtBQVdNQjhoNjFZT3ktM0J2M2gxNFFwMmVMUDFqVzNrNERfQ0p0VFJxVTc1MEZ4QmdFSDk5bl9Ebjc2eFYzMnYyMGdtdjJKd0tyQQ?oc=5", "source_name": "BioSpace", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQSjBJOHplZUthVDVqSy1qUmxhdmxrRFZRaDZMRW9YT1NzNVFlcW9sOU1FRkRYVHQyazBPRWlmd1piRkJVZFZnUGJrdzRSeXJzeHdaVnJKRGNtOUk4X0RpQVVBV2dxaEc2eHN5ZEpjSzlOUXJFRFFRM1RTWjdLczhUWEpyRTVwejE2OExZbU1wYXV0OGs5cVE?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb Inc (OABI) Q1 2026 Earnings Report Preview: What To Expect", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/omniab-inc-oabi-q1-2026-133357783.html", "source_name": "GuruFocus.com", "published_at": "2026-05-06T13:33:57+00:00", "published_display": "06 May 2026 13:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buyers At OmniAb Likely Disappointed With 13% Slide", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bullish OmniAb Insiders Loaded Up On US$1.28m Of Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPWW91NXZENlJWNmJobnFiX2FXYlB4UXlsVzc2dGJnc1JCVE92X2lNZEhSRUxHd01Jcm9wbGN5V25YdUlpWmR3MFZqX3c3dXotSGFHMWRFaGx3QlNsdEVKZGV0SzFqN0R3cDc5UUlqNl9qZFJJT0F6TU1qN1Qxc19vWjNCSEsxYldvS2VNclZLcEhnTXdLLXJCUWRBS0ozZk0?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Well-Positioned for Momentum Build-Up in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObTJZdy05WU51OW9zX09RTGdDZ2lQOFlBU21ELUU4R2pvMTFXdlktV2p2TWEwLW1ENEJUN2Utd1ZpcHJUM3BKUHFucGc5cUtidUt1U1J4Ti12MFJBOFA2UGtuY3V3b1ZoalVncVNaTGc5VzFiV013OFA2UWlPTlRvOG1qZmdLTUhDeGRjZlpKc3pyWEk5UExHdlhZUi15Q19UM251dzdkUW4?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Is Why You Should Not Ignore OmniAb Inc. (OABI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNMFlYYXdrUy14LTJnN2xjWTlJOWZPSWxFY3hvdkZ2d25WMklQcDVFOUpPMDd5NEhvMVBVLVFvbS10ejY4TUVEMDgzQ2M4b1JpWUlFRHNRbGRYeG54OEJxdHV5a29sUmVuWkRkN2ZqdURQWWIzcDU1OUc5VEV5NmktOHlvdWFLOTFldm83dWZWMmlYdjRV?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OmniAb (OABI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBReWlfUUNXWkkzUTcxLWZ1cWF5aXUwc1ZHckYzWDBlODh4R2xHRlE3N2tLTV9uRUY5VUNyUERaR282ZHJvUkY0eUtydGlwak9xWTFZ?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:41:42+00:00", "published_display": "25 Apr 2025 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRU9nT1I3VkhzbF9peGZ1UklHRU1idVdXSy0tdnRmWS1wb0Izc1ZteW1xRnUyZ0t3RWloQzMxWnB0MkdUYWdMSUhwUl92MG5mVmkzTEtQa3ZReDdhMzNMMFhIeHNNME9yUlg5UkRmUDVGS3hmUEVvc2ZCcWhvUHNLSmdQTlBpaU9PR2MxbTVGVGtkUGxabDJSWUZtVHBYZThBUmtYclAyZmh3bjd2S2JiT2JEWXF6MUp5U3JxRFk2clRvX0lIcDFVTUZ6cm9HSm1OWGlEMVBONk5JV0NQZnp4OWtPT1E?oc=5", "source_name": "Business Wire", "published_at": "2022-03-23T07:00:00+00:00", "published_display": "23 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 89, "total_relevant": 54, "sentiment_summary": {"positive": 13, "negative": 6, "neutral": 35, "score": 52, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 13.75, "count": 25}, {"event": "earnings", "label": "Earnings", "weight": 11.9, "count": 23}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 2.29, "latest_week": "2026-07-10", "one_week_move": -5.4, "four_week_move": 0.9, "twelve_week_move": 39.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.763227, "market_dynamics_buy_signal": false, "relative_strength": 5.856932, "fair_value_gap": -32.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.1909, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.4% over one week, +0.9% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "TradingView", "count": 9}, {"label": "Stock Titan", "count": 4}, {"label": "simplywall.st", "count": 4}, {"label": "www.marketscreener.com", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "Finviz", "count": 2}, {"label": "Moomoo", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 46}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 25}, {"label": "Earnings", "count": 23}, {"label": "Analyst action", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "46", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-5.4% over one week, +0.9% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "OmniAb Names Amechi Nwachuku Chief Operating Officer"}], "updated_at": "2026-07-16T04:49:52.455294+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}